Clinical Trial Update: Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab

View source ↗

Summary

This completed clinical trial update discusses biomarker analyses in samples from patients with Follicular lymphoma treated with Rituximab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Status: COMPLETED